Artiva Biotherapeutics is an immunotherapy company with the ability to produce off-the-shelf, allogeneic NK cell therapies at a massive scale. Our mission is to develop effective, safe and accessible cell therapies for patients with devastating autoimmune diseases and cancers. Our lead program, AlloNK®, is an allogeneic, non-genetically modified NK cell therapy candidate designed to enhance the activity of monoclonal antibodies or NK cell engagers. AlloNK is currently in clinical trials in combination with rituximab for treatment of systemic lupus erythematosus (SLE) in patients with active lupus nephritis and for treatment of Non-Hodgkin Lymphoma, as well as in combination with Affimed’s innate cell engager AFM13 for the treatment of patients with relapsed/refractory CD30-positive lymphomas.
Company Details
- Employees
- 104
- Founded
- -
- Address
- 5505 Morehouse Drive, Suite 100, San Diego,california 92121,united States
- Phone
- 858-267-4467
- in****@****bio.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- artivabio.com
- Keywords
- cell therapy, cancer, nk cells, nk cell therapy, car-nk.
- HQ
- San Diego, California
Artiva Biotherapeutics Questions
Artiva Biotherapeutics's helpline number is 858-267-4467
Artiva Biotherapeutics's website is artivabio.com
Artiva Biotherapeutics's LinkedIn profile is https://www.linkedin.com/company/artiva-biotherapeutics
Artiva Biotherapeutics has
104 employees.
View email and phone details for 104
employees at Artiva Biotherapeutics.
Artiva Biotherapeutics's industry is
Biotechnology Research
Artiva Biotherapeutics's top competitors are
Poseida Therapeutics, Inc.,
Shoreline Biosciences, Inc.,
Crinetics Pharmaceuticals,
Neurocrine Biosciences,
Aspen Neuroscience, Inc.,
Avidity Biosciences, Inc.,
Janux Therapeutics,
Ionis Pharmaceuticals, Inc.,
Fate Therapeutics Inc.,
Capstan Therapeutics.
Artiva Biotherapeutics's support email address is info@artivabio.com
Artiva Biotherapeutics's categories are Biotechnology Research
Artiva Biotherapeutics's founding year is 2019
